LoginUnderstanding the ABCs of CBD
Laura Phillips examines the legal context within which the CBD sector operates
Posted 07 June 2022 | JoTS Online
Content Tags: Analysis|Legal and Policy|National
ANALYSIS: Rapid growth in the CBD market has created complex regulatory challenges. This analysis explains the legal status of cannabidiol, the distinction from medicinal cannabis, novel food requirements and the practical enforcement issues facing Trading Standards.
CBD (cannabidiol) is a chemical compound extracted from cannabis. Unlike THC (tetrahydrocannabinol), the other main compound found in the cannabis plant, and the one which is responsible for the psychoactive effects (the ‘high’), CBD is not considered to be illegal under the Misuse of Drugs Act 1971 and associated legislation. It is not the same as CBPM (medicinal cannabis) which is also legal,...
CTSI Member-Only Content
This content can only be accessed by logged-in members of CTSI.
Already a member? Please enter your details below. If your login is successful, the page will automatically refresh and the full content will be visible.
Why join CTSI?
The Chartered Trading Standards Institute (CTSI) is the representative body for UK Trading Standards and Regulatory Compliance professionals - and one of the largest, oldest (est. 1881) and most respected consumer protection organisations in the world.
As a non-profit campaigning organisation (see our Latest Campaigns), our strength, our voice and our ability to influence government, industry and the media, and shape public opinion comes directly from our membership, who are organised in an active network of branches, regions and special interest groups around the country. We are stronger together.
Interested in becoming a Member of CTSI?
Read about our various Membership Options - from Full Membership (qualified Trading Standards professionals) to Associate Membership (consumer protection supporters).
